Valeo Pharma Inc T.VPH

Alternate Symbol(s): T.VPH.DB | VPHIF

Healthcare

Valeo Pharma Inc. is a Canadian pharmaceutical company. The Company acquires, or in-licenses branded pharmaceuticals and hospital specialty products for sale in Canada. The Company is engaged in the commercialization of prescription products in Canada with a focus on respiratory/allergy, ophthalmology and hospital specialty products. Its respiratory/allergy products include Enerzair Breezhaler, Atectura Breezhaler and Allerject. The ophthalmology products include Xiidra and Simbrinza. Its specialty products include Redesca, Onstryv, M-Eslon, Yondelis and Ametop Gel 4%. The Company's wholly owned subsidiary is VPI Pharmaceuticals Inc.

TSX:VPH - Post by User

Valeo Pharma Inc > Liftoff soon? Should be just about done working

<< Previous

Bullboard Posts

Next >>

Comment by kooter33on Jan 28, 2021 3:18pm

134 Views

Post# 32412454

RE:RE:Liftoff soon? Should be just about done working

CamWisdom wrote: I think it goes higher than $2 this year.
- Cam

I am counting on it. IF they can show the kind of revenues that they are predicting in their models for each product, then $ 2 will be really cheap. IMO, 2021 will be the breakout year for VPH.
Back of the envelope calculations: 2021 - $30M revenues at 30% ROI divided by the O/S shares of 65M = 13.8 cents per share X a conservative PE ratio of 20 = $2.77/sh.
this is ultra-conservative. 2022 is when the really value will show up. IMO, this will be north of $ 5 come end of 2022.

<< Previous

Bullboard Posts

Next >>

High-quality lithium projects in Argentina with drilling underway